ArticleJournal of health, population, and nutrition2014
Cost of illness due to typhoid Fever in pemba, zanzibar, East Africa.
Article in Journal of health, population, and nutrition, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 2 syntheses or guidelines pooled it, 22 citations in OpenAlex.
- Resource use, availability and cost in the provision of critical care in Tanzania: a systematic review.BMJ open · 2022Pooled it
- The global burden of typhoid and paratyphoid fevers: a systematic analysis for the Global Burden of Disease Study 2017.The Lancet. Infectious diseases · 2019Pooled it
- Economic burden of typhoid among hospitalised children in Kenya.BMJ global health · 2026Article
- Examining epidemiological models and economic analyses of typhoid conjugate vaccine: A scoping review.PLOS global public health · 2026Article
- The cost of typhoid illness in low- and middle-income countries, a scoping review of the literature.PloS one · 2024Article
- Typhoid fever.Nature reviews. Disease primers · 2023Review
- Taking on Typhoid: Eliminating Typhoid Fever as a Global Health Problem.Open forum infectious diseases · 2023Article
- Typhoid Control in an Era of Antimicrobial Resistance: Challenges and Opportunities.Open forum infectious diseases · 2023Article
- Estimating the economic burden of typhoid in children and adults in Blantyre, Malawi: A costing cohort study.PloS one · 2022Article
- Typhoid and Paratyphoid Cost of Illness in Pakistan: Patient and Health Facility Costs From the Surveillance for Enteric Fever in Asia Project II.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2020Article
- Typhoid and Paratyphoid Cost of Illness in Nepal: Patient and Health Facility Costs From the Surveillance for Enteric Fever in Asia Project II.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2020Article
- Typhoid and Paratyphoid Cost of Illness in Bangladesh: Patient and Health Facility Costs From the Surveillance for Enteric Fever in Asia Project II.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2020Article
- Methodological Considerations for Cost of Illness Studies of Enteric Fever.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2020Article
- A Multicenter Cost-of-Illness and Long-term Socioeconomic Follow-up Study in the Severe Typhoid Fever in Africa Program: Study Protocol.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2019Article
- Cost-effectiveness of routine and campaign use of typhoid Vi-conjugate vaccine in Gavi-eligible countries: a modelling study.The Lancet. Infectious diseases · 2019Article
- A Review of the Economic Evidence of Typhoid Fever and Typhoid Vaccines.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2019Review
- Cost-effectiveness analysis of typhoid conjugate vaccines in five endemic low- and middle-income settings.Vaccine · 2017Article
- A review of typhoid fever transmission dynamic models and economic evaluations of vaccination.Vaccine · 2015Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors at 5 institutions in 5 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The aim of this study was to estimate the economic burden of typhoid fever in Pemba, Zanzibar, East Africa. This study was an incidence-based cost-of-illness analysis from a societal perspective. It covered new episodes of blood culture-confirmed typhoid fever in patients presenting at the outpatient or inpatient departments of three district hospitals between May 2010 and December 2010. Cost of illness was the sum of direct costs and costs for productivity loss. Direct costs covered treatment, travel, and meals. Productivity costs were loss of income by patients and caregivers. The analysis included 17 episodes. The mean age of the patients, was 23 years (range=5-65, median=22). Thirty-five percent were inpatients, with a mean of 4.75 days of hospital stay (range=3-7, median=4.50). The mean cost for treatment alone during hospital care was US$ 21.97 at 2010 prices (US$ 1=1,430.50 Tanzanian Shilling─TSH). The average societal cost was US$ 154.47 per typhoid episode. The major expenditure was productivity cost due to lost wages of US$ 128.02 (83%). Our results contribute to the further economic evaluation of typhoid fever vaccination in Zanzibar and other sub-Saharan African countries.
Indexed as
Identifiers
25395900PMC4221443W2112233033What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.